argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France.
Argenx Se stock last closed at $393.26, down 2.25% from the previous day, and has increased 40.97% in one year. It has overperformed other stocks in the Biotechnology industry by 0.73 percentage points. Argenx Se stock is currently +57.62% from its 52-week low of $249.50, and -3.6% from its 52-week high of $407.93.
As of Dec 5, 2022, there are 55.06M ARGX shares outstanding. The market capitalization of ARGX is $21.65B. In the last 24 hours, 228,010 ARGX shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy ARGX stock.
Based on our research, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro now.Open eToro Account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to buy ARGX stock today.
Watch this video walkthrough for more details depositing money into your brokerage account.
It's critical to analyze stocks prior to buying, so you truly comprehend the risk and opportunity.
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ARGX's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge ARGX's intrinsic value.
Using relative valuations ratios:
You can do additional valuation research on ARGX's stock here.
Out of 13 sell side analysts who monitor ARGX, the consensus analyst rating on ARGX is a Strong Buy
Matthew Harrison, a bottom 3% analyst from Morgan Stanley maintains ARGX with a strong buy rating and raises their ARGX price target from $401.00 to $450.00, on Oct 28, 2022.
Joon Lee, a bottom 14% analyst from Truist Securities maintains ARGX with a strong buy rating and raises their ARGX price target from $410.00 to $420.00, on Oct 28, 2022.
Douglas Tsao, a top 21% analyst from HC Wainwright & Co. maintains ARGX with a buy rating and raises their ARGX price target from $425.00 to $440.00, on Oct 28, 2022.
Thomas Smith, a bottom 5% analyst from SVB Leerink maintains ARGX with a buy rating and raises their ARGX price target from $428.00 to $430.00, on Oct 28, 2022.
Derek Archila, a top 4% analyst from Wells Fargo maintains ARGX with a strong buy rating and raises their ARGX price target from $461.00 to $469.00, on Oct 18, 2022.
Archila bumped up his price target on Argenx SE by 1.7%.
The company will likely post "solid growth" for Q3 and Q4 2022, the analyst told investors, citing a survey on physicians who prescribe Vyvgart*.
The recent weakness in the shares following Symphony data** suggesting a decline in Vyvgart sales in 2022/09 "offers a nice setup" for the Q3 earnings report, Archila said.
Explaining his bullish thesis, the analyst contended that the data likely does not accurately reflect Vyvgart volumes.
Argenx "should at least meet, but more likely beat consensus," Archila argued, citing his "bullish responses" from his own survey.
* From here: Efgartigimod alfa, sold under the brand name Vyvgart, is a medication used to treat myasthenia gravis.
** From here: Symphony Data is a health care and insurance administrative outsourcing and information management services provider.
You can dig deeper into what analysts are forecasting on the Argenx Se stock forecast page.
Last year, ARGX revenue was $29.79M. Over the last five year, ARGX's revenue has increased by -2.92% per year. This was slower than the Biotechnology industry average of 80.69%.
Dig into ARGX's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at ARGX have not bought or sold any shares.
Learn more about who owns ARGX shares here.
No, Argenx Se doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary order types:
Click the Open Trade button and your broker will execute the order.
If you require more info about investing in stocks on eToro, click the helpful video below:
Now that you own some shares in ARGX, you'll want to keep up with your new stock purchase.
Make a watchlist to get alerted to the latest events about your ARGX stock.
To summarize, here are the 6 steps to buy Argenx Se stock:
If you need a brokerage, eToro is our favorite venue.Get Started with eToro Today
If you want to get updates on your investment in Argenx Se, create a watchlist on WallStreetZen today.
How much does it cost to buy one Argenx Se share?
Is now a good time to buy Argenx Se stock?
What is the best way to buy Argenx Se stock?